Jonathan Schapiro

9.0k total citations · 1 hit paper
83 papers, 5.9k citations indexed

About

Jonathan Schapiro is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Jonathan Schapiro has authored 83 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Infectious Diseases, 62 papers in Virology and 16 papers in Hepatology. Recurrent topics in Jonathan Schapiro's work include HIV/AIDS drug development and treatment (65 papers), HIV Research and Treatment (62 papers) and HIV/AIDS Research and Interventions (46 papers). Jonathan Schapiro is often cited by papers focused on HIV/AIDS drug development and treatment (65 papers), HIV Research and Treatment (62 papers) and HIV/AIDS Research and Interventions (46 papers). Jonathan Schapiro collaborates with scholars based in United States, Israel and Netherlands. Jonathan Schapiro's co-authors include Robert W. Shafer, Daniel R. Kuritzkes, Deenan Pillay, Bonaventura Clotet, Françoise Brun‐Vézinet, Victoria A. Johnson, Charles A. Boucher, Douglas D. Richman, Soo‐Yon Rhee and Mark A. Winters and has published in prestigious journals such as Nature Genetics, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Jonathan Schapiro

81 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

2009 731 citations Ricardo Camacho, Daniel R. Kuritzkes et al. profile →

Peers

Countries citing papers authored by Jonathan Schapiro

Since Specialization

Citations

This map shows the geographic impact of Jonathan Schapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Schapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Schapiro more than expected).

Fields of papers citing papers by Jonathan Schapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Schapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Schapiro. The network helps show where Jonathan Schapiro may publish in the future.

Co-authorship network of co-authors of Jonathan Schapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Schapiro. A scholar is included among the top collaborators of Jonathan Schapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Schapiro. Jonathan Schapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiometabolic health in people with HIV: expert consensus review 2024 ·Journal of Antimicrobial Chemotherapy ·Rachel L. Batterham, Roger Bedimo, Ricardo Sobhie Diaz, Giovanni Guaraldi, Janet Lo, Estebán Martínez, Grace A. McComsey, Ana Milinkovic, (unknown), Sebastian Noé, Donal O’Shea, Roger Paredes, Jonathan Schapiro, Mark Sulkowski, François Venter, Laura Waters, (unknown), Benjamin Young	7
2	A systematic review of adeno‐associated virus gene therapy clinical trials for HIV – A potential solution for patients with haemophilia and HIV? 2023 ·Haemophilia ·Sarina Levy‐Mendelovich, Christopher Walsh, Jonathan Schapiro, Shelly Soffer, Eyal Klang, Gili Kenet	1
3	Genotypic Impact of Prolonged Detectable HIV Type 1 RNA Viral Load after HAART Failure in a CRF01_AE-Infected Cohort 2010 ·AIDS Research and Human Retroviruses ·María Zolfo, Jonathan Schapiro, (unknown), Olivier Koole, Sopheak Thai, Marc Vekemans, Katrien Fransen, Lutgarde Lynen	14
4	Nucleoside reverse transcriptase inhibitors in combination therapy for HIV patients: systematic review and meta-analysis 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·Michal Chowers, (unknown), Leonard Leibovici, Jonathan Schapiro, Mical Paul	12
5	Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV‐1‐infected patients with multidrug‐resistant virus: a multicentre pilot study 2008 ·HIV Medicine ·Josep M. Llibre, Anna Bonjoch, (unknown), (unknown), Eugènia Negredo, Peré Domingo, Núria Pérez‐Álvarez, Javier Martínez‐Picado, Jonathan Schapiro, Bonaventura Clotet, (unknown)	11
6	Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience 2008 ·Haemophilia ·‪Yasmin Maor‬‏, Jonathan Schapiro, Dalia Bashari, Yoav Lurie, Rifaat Safadi, Ori Segol, (unknown), (unknown), Benjamin Avidan, Simon Bar–Meir, U. Martinowitz	7
7	A randomized, controlled study evaluating an induction treatment strategy in which enfuvirtide was added to an oral, highly active antiretroviral therapy regimen in treatment-experienced patients: the INTENSE study 2008 ·Journal of Antimicrobial Chemotherapy ·Bonaventura Clotet, Amedeo Capetti, Luis Enrique Soto-Ramírez, José M. Gatell, Lucy Rowell, Miklos Salgo, Jonathan Schapiro	5
8	Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C‐infected haemophilia patients 2007 ·Haemophilia ·‪Yasmin Maor‬‏, Paul Calès, Dalia Bashari, Gili Kenet, Aharon Lubetsky, Jacob Luboshitz, Jonathan Schapiro, Guillaume Pénaranda, Simon Bar–Meir, U. Martinowitz, Philippe Halfon	14
9	Drug Development Strategies for Salvage Therapy: Conflicts and Solutions 2006 ·AIDS Research and Human Retroviruses ·Victor De Gruttola, Charles Flexner, Jonathan Schapiro, Michael Hughes, Mark van der Laan, Daniel R. Kuritzkes	8
10	Diminished Selection for Thymidine-Analog Mutations Associated With the Presence of M184V in Ethiopian Children Infected With HIV Subtype C Receiving Lamivudine-Containing Therapy 2006 ·The Pediatric Infectious Disease Journal ·Diana Averbuch, Jonathan Schapiro, E. Randall Lanier, (unknown), Giora Gottesman, (unknown), M. Einhorn, Galia Grisaru‐Soen, Michal Ofir, Dan Engelhard, Zehava Grossman	16
11	HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes 2006 ·AIDS ·Soo‐Yon Rhee, Rami Kantor, David Katzenstein, Ricardo Camacho, Lynn Morris, Sunee Sirivichayakul, (unknown), Luís Fernando de Macedo Brígido, Jonathan Schapiro, Robert W. Shafer	72
12	Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV‐infected patients experiencing prolonged virologic failure 2004 ·Journal of Medical Virology ·Eva Poveda, Berta Rodés, Jean‐Louis Labernardière, José M. Benito, Carlos Toro, Juan González‐Lahoz, (unknown), François Clavel, Jonathan Schapiro, Vincent Soriano	65
13	HIV-1 Protease and Reverse Transcriptase Mutation Patterns Responsible for Discordances Between Genotypic Drug Resistance Interpretation Algorithms 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Bradley J. Betts, Françoise Brun‐Vézinet, Anne–Mieke Vandamme, Diane Descamps, Kristel Van Laethem, K.M. Smith, Jonathan Schapiro, Dean L. Winslow, Caroline Reid, Robert W. Shafer	74
14	Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients 2002 ·HIV Clinical Trials ·(unknown), Éric Cua, (unknown), J. Durant, (unknown), Ronan Boulmé, Jacqueline Cottalorda, (unknown), Jonathan Schapiro, F Clavel, P. Dellamonica	14
15	Drug‐induced and traumatic nail problems in the haemophilias 2000 ·Haemophilia ·M. Heim, Jonathan Schapiro, (unknown), U. Martinowitz	6
16	Methods for Investigation of the Relationship between Drug‐Susceptibility Phenotype and Human Immunodeficiency Virus Type 1 Genotype with Applications to AIDS Clinical Trials Group 333 2000 ·The Journal of Infectious Diseases ·Anne Sevin, Victor DeGruttola, Monique Nijhuis, Jonathan Schapiro, Andrea S. Foulkes, Michael F. Para, Charles A. Boucher	67
17	Economic Evaluation of Drug Resistance Genotyping for the Adaptation of Treatment in HIV-Infected Patients in the VIRADAPT Study 2000 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Carine Chaix, (unknown), Philippe Clevenbergh, J. Durant, Jonathan Schapiro, P. Dellamonica, Isabelle Durand‐Zaleski	28
18	Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations 1999 ·AIDS ·Jonathan Schapiro, Mark A. Winters, Jody Lawrence, Thomas C. Merigan	41
19	Localization of a gene causing cystinuria to chromosome 2p 1994 ·Nature Genetics ·Elon Pras, Nadir Arber, Ivona Aksentijevich, Giora Katz, Jonathan Schapiro, (unknown), Luis Gruberg, (unknown), Uri Liberman, Jean Weissenbach, Mordechai Pras, Daniel L. Kastner	77
20	Typhoid Fever in Ethiopian Immigrants to Israel and Native-Born Israelis: A Comparative Study 1993 ·Clinical Infectious Diseases ·Yehuda Carmeli, Raanan Raz, Jonathan Schapiro, (unknown)	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact